Skip to main content

Medications for Opioid Use Disorder Save Lives (2019) / Chapter Skim
Currently Skimming:

Appendix B: Public Workshop Agenda
Pages 141-148

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 141...
... Director, Office of Financial Resources Substance Abuse and Mental Health Services Administration •  Rebecca Baker, Ph.D.  Special Assistant to the Director National Institutes of Health 1:30pm Sponsor Q&A with Committee • Alan I
Read the entire page →
From page 142...
... Moderator: • Alan I Leshner, Committee Chair Chief Executive Officer Emeritus American Association for the Advancement of Science Panelists: • Nora Volkow, National Institute on Drug Abuse • Deepa Avula, Substance Abuse and Mental Health ­Services Administration • Molly Evans, U.S.
Read the entire page →
From page 143...
... • Identify evidence gaps that might contribute to limited effec tiveness of specific medications or limit the use of medica tions in treating OUD, i.e., dosing ranges, optimal duration of treatments, discontinuation, optimal duration of tapering medication, and real-world evidence on patient experiences and preferences. • For each medication, examine the regulations, infrastruc ture, and care settings required for delivery of specific medi cations for OUD, and explore how this influences patient and provider preference when selecting treatment.
Read the entire page →
From page 144...
... •  Identify best practices and education for policy makers, law enforcement, the public, and other stakeholders. Moderator: Chinazo Cunningham, Albert Einstein College of Medicine Panelists: • Jeanette Tetrault, Yale University • Stephen Patrick, Vanderbilt University • Eugenia Oviedo-Joekes, University of British Columbia • Jules Netherland, Drug Policy Alliance • Kathleen Johnson, Advocates for Opioid Recovery 3:15pm BREAK
Read the entire page →
From page 145...
... Leshner, Committee Chair, Chief Executive Officer Emeritus, American Association for the Advancement of Science 5:15pm Adjourn
Read the entire page →
From page 146...
... •  Identify further evidence needed to better deliver culturally appropriate care and serve diverse populations. Moderator: David Patterson Silver Wolf, Washington University •  Panelists: • Helena B
Read the entire page →
From page 147...
... Leshner, Committee Chair Chief Executive Officer Emeritus American Association for the Advancement of Science
Read the entire page →
From page 148...
... 148 MEDICATIONS FOR OPIOID USE DISORDER SAVE LIVES 12:30pm Meeting Recap and Closing Remarks • Alan I Leshner, Committee Chair Chief Executive Officer Emeritus American Association for the Advancement of Science 12:45pm Adjourn
Read the entire page →

Key Terms

  • panelist presentations
  • committee chair
  • substance abuse
  • drug abuse
  • treating oud

  • specific medications
  • diverse populations
  • appropriate care
  • chinazo cunningham
  • identify patient

  • addiction policy
  • improve treatment
  • silver wolf
  • patient outcome
  • allan coukell

  • federal initiatives
  • nora volkow
  • treatment workforce
  • bloomberg school
  • einstein college

  • albert einstein
  • process measures
  • federal efforts
  • profit treatment
  • current federal

  • drug policy
  • mason university
  • virginia commonwealth
  • patient preferences
  • officer emeritus


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.